ANN ARBOR, Mich. – A recent study reveals that the Inflation Reduction Act (IRA) could save Medicare beneficiaries over $7,000 per year on out-of-pocket costs for common oral cancer medications. This significant reduction in expenses comes as a relief to many patients who have long struggled with the financial burden of cancer treatment.